Skip to main content

LA49 Pill - white capsule/oblong

Pill with imprint LA49 is White, Capsule/Oblong and has been identified as Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg / 300 mg. It is supplied by Laurus Labs Limited.

Emtricitabine/tenofovir is used in the treatment of Pre-Exposure Prophylaxis; Nonoccupational Exposure; HIV Infection; Occupational Exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Emtricitabine/tenofovir 200 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LA49

Emtricitabine and tenofovir disoproxil fumarate 200 mg / 300 mg LA49

Emtricitabine and Tenofovir Disoproxil Fumarate

Imprint
LA49
Strength
200 mg / 300 mg
Color
White
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Antiviral combinations
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Laurus Labs Limited
National Drug Code (NDC)
42385-0913

Get help with Imprint Code FAQs.

Related images for "LA49"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.